Europe Atopic Dermatitis Epidemiology and Patient Flow Analysis - 2017

Europe Atopic Dermatitis Epidemiology and Patient Flow Analysis - 2017

  • January 2017 •
  • Report ID: 4835098 •
  • Format: PDF
Fore Pharma announced the results of its Atopic Dermatitis patients study in a new report ‘Europe Atopic Dermatitis Epidemiology and Patient Flow Analysis - 2017’.

The report provides insights into Atopic Dermatitis epidemiology, Atopic Dermatitis diagnosed patients, and Atopic Dermatitis treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of Atopic Dermatitis derived from epidemiological analysis, percentage of patients diagnosed with Atopic Dermatitis, and percentage of patients treated with a therapy.

The study helps executives estimate Atopic Dermatitis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Atopic Dermatitis prevalence, Atopic Dermatitis diagnosis rate, and Atopic Dermatitis treatment rate for the period 2016 - 2025. The information is presented by leading geographies including Germany, France, Spain, Italy, and UK. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:
- Atopic Dermatitis Patient Flow
- Atopic Dermatitis Prevalence
- Atopic Dermatitis Diagnosed Patients
- Atopic Dermatitis Treated Patients